Infection prevention and control adherence among SARS-CoV-2 infected healthcare workers in Addis Ababa, Ethiopia: lessons for future outbreaks.

Publication date: Aug 12, 2026

Health care worker (HCW) infections during outbreaks of high-consequence pathogens, from SARS-CoV-2 to Ethiopia’s 2025-2026 Marburg outbreak, highlight persistent Infection Prevention and Control (IPC) gaps. We evaluated IPC adherence and its determinants among infected HCWs in Addis Ababa, Ethiopia, to inform future outbreak preparedness. This census-based cross-sectional study (March 2020-March 2021) evaluated 1152 SARS-CoV-2-infected HCWs with clinical exposures 14 days pre-diagnosis. Environments were classified via an adapted OSHA pyramid into: High-Pathogen Designated Areas isolation and treatment units, General High-Risk Areas [intensive care units, emergency departments, and operating theaters], Medium-Risk Clinical Areas [inpatient and outpatient departments], and Low-Risk Support Areas [administrative and non-clinical zones]. Adherence was defined as correct practice in > 50% of interactions. Bivariate chi-square tests and multivariable logistic regression identified independent determinants for donning/doffing (n = 742) and N95 seal-checks (n = 350), reporting adjusted odds ratios (aOR) with 95% confidence intervals at P  30 [aOR = 0. 57 (0. 34-0. 98)] and stress [aOR = 0. 46 (0. 28-0. 77)] were negative determinants. This study underscores IPC gaps among HCWs especially in non-designated areas, where most infections occurred, highlighting the need for standardized IPC across all healthcare environments.

Open Access PDF

Concepts Keywords
COVID-19
Cross-sectional studies
Ethiopia
Guideline adherence
Health Personnel
Infection control
Occupational exposure
Personal protective equipment

Semantics

Type Source Name
disease MESH Infection
disease MESH persistent Infection
disease MESH emergency
pathway REACTOME Reproduction
disease MESH included
disease MESH COVID 19
disease MESH critical illness
disease MESH face
disease MESH Marburg Virus Disease
disease MESH infectious diseases
disease MESH LRS
disease MESH dis
drug DRUGBANK Etoperidone
disease MESH ers
drug DRUGBANK Hyaluronic acid
disease MESH fever
drug DRUGBANK Coenzyme M
disease MESH mend
drug DRUGBANK Sodium lauryl sulfate
disease MESH SDs

Original Article

(Visited 8 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *